HIGHLIGHTS
- who: Haowen Jiang et al. from the Washington University in StLouis, United States have published the Article: The magic bullet: Niclosamide, in the Journal: (JOURNAL)
- what: The authors propose the mitochondrial uncoupler niclosamide can serve as a compound to target cancer metabolic reprogramming.
- future: Nonetheless additional studies are needed to elucidate the primary target of niclosamide as an anti-tumor compound. These properties are associated with diverse biopharmaceutical challenges such as the relationship between physicochemical properties and oral absorption of the drug with Conclusions and future directions Cancer is the second leading cause . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.